A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)-Reference-Cited by-同舟云学术

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

Published:2008-11 Issue:16 Volume:44 Page:2453-2460
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Vassal Gilles,Giammarile Francesco,Brooks Mariel,Geoerger Birgit,Couanet Dominique,Michon Jean,Stockdale Elizabeth,Schell Matthias,Geoffray Anne,Gentet Jean-Claude,Pichon Fabienne,Rubie Hervé,Cisar Laura,Assadourian Sylvie,Morland Bruce

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Paediatric Oncology (SFOP) protocol;Valteau-Couanet;J Clin Oncol,2005

2. For the Children’s Cancer Group. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-Retinoic Acid;Matthay;N Engl J Med,1999

3. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against paediatric and adult central nervous system tumour xenografts;Hare;Cancer Chemother Pharmacol,1997

4. Potent therapeutic activity of irinotecan and its schedule dependency in medulloblastoma xenografts in nude mice;Vassal;Int J Cancer,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma;Cancer;2023-04-20

2. Recent advances in SN-38 drug delivery system;International Journal of Pharmaceutics;2023-04

3. Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models;International Journal of Molecular Sciences;2022-02-03

4. Registration‐directed phase 1/2 trial of irinotecan for pediatric solid tumors;Pediatrics International;2019-05

5. Current and Future Strategies for Treatment of Relapsed Neuroblastoma;Neuroblastoma;2019